Diurnal : Director Dealings

18 May 2018

Diurnal Group plc

('Diurnal' or the 'Company')

Director Dealings

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that it has been notified of the following transaction in the Company's ordinary shares undertaken by Alan Raymond, Non-Executive Director, as a result of a re-registration to a nominee account. There has been no change of beneficial ownership as a result of this transfer of legal title.

For further information, please visitwww.diurnal.co.ukor contact:
Diurnal Group plc	[phone]
Martin Whitaker, Chief Executive Officer
Richard Bungay, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker)	[phone]
Corporate Finance: Freddy Crossley, Emma Earl
Corporate Broking: James Stearns
Cantor Fitzgerald Europe (Joint Broker)	[phone]
Corporate Finance: Phil Davies, Will Goode, Michael Boot Healthcare Equity Sales: Andrew Keith
FTI Consulting	[phone]
Simon Conway
Victoria Foster Mitchell

Notes to Editors

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visitwww.diurnal.co.uk

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Alan Raymond
2	Reason for the notification
a)	Position/status	Non-executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Diurnal Group plc
b)	LEI	213800I2HNUNZN1LDH29
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 5 pence each in Diurnal Group plc
	Identification code	GB00BDB6Q760
b)	Nature of the transaction	Re-registration of ordinary shares with Redmayne Bentley Stockbrokers
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil	19,888
d)	Aggregated information	n/a
e)	Date of the transaction	14 May 2018
f)	Place of the transaction	Outside a trading venue